Literature DB >> 28139096

Simultaneous determination of eight Danshen polyphenols in rat plasma and its application to a comparative pharmacokinetic study of DanHong injection and Danshen injection.

Xiuxue Li1,2, Feifei Du1, Weiwei Jia1, Olajide E Olaleye1, Fang Xu1, Fengqing Wang1, Li Li1.   

Abstract

Polyphenols derived from Danshen are responsible for the therapeutic effects of DanHong injection, a two-herb combination of Danshen and Honghua. Whether the pharmacokinetics of Danshen polyphenols is changed by coexisting Honghua constituents remains unknown. A sensitive ultra high performance liquid chromatography with tandem mass spectrometry method was developed in this study for simultaneous determination of eight Danshen polyphenols (i.e., protocatechuic aldehyde, protocatechuic acid, tanshinol, salvianolic acid D, rosmarinic acid, salvianolic acid A, lithospermic acid, and salvianolic acid B) in rat plasma and applied to a comparative pharmacokinetic study of DanHong injection and Danshen injection. Liquid chromatography conditions, mass spectrometry parameters, and sample preparation were optimized step by step. The calibration curves showed good linearity (r > 0.99) for all the polyphenols. The mean extraction efficiencies ranged from 62.2 to 88.7% with negligible matrix effects. The intrabatch and interbatch precision at all the quality control levels were less than 15% of the nominal concentrations with accuracy of 88.8-114%, except that precision and accuracy at lower limit of quantitation were 3.2-17.3 and 95.7-119%, respectively. Comparative pharmacokinetic study suggested that the coexisting Honghua constituents might have negligible influences on the pharmacokinetics of Danshen polyphenols from DanHong injection. The bioanalytical method could also be applied to pharmacokinetic studies of other Danshen herbal products.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  DanHong injection; Danshen injection; pharmacokinetics; polyphenols; traditional Chinese medicine

Mesh:

Substances:

Year:  2017        PMID: 28139096     DOI: 10.1002/jssc.201601340

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  5 in total

1.  Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.

Authors:  Xiuli Fang; Yajun Liu; Jing Lu; Huiqi Hong; Jing Yuan; Yuhong Zhang; Panxia Wang; Peiqing Liu; Jiantao Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-21       Impact factor: 3.000

2.  DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy.

Authors:  Min-Yu Zhang; Fei-Fei Guo; Hong-Wei Wu; Yang-Yang Yu; Jun-Ying Wei; Shi-Feng Wang; Yu-Xin Zhang; Ming-Hua Xian; Qing-Hua Wu; Bu-Chang Zhao; Shi-You Li; Hong-Jun Yang
Journal:  Oncotarget       Date:  2017-10-13

3.  Inhibition of FOXO3a/BIM signaling pathway contributes to the protective effect of salvianolic acid A against cerebral ischemia/reperfusion injury.

Authors:  Junke Song; Wen Zhang; Jinhua Wang; Haiguang Yang; Qimeng Zhou; Haigang Wang; Li Li; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2019-01-24       Impact factor: 11.413

4.  Rapid Screening and Quantitative Determination of Active Components in Qing-Hua-Yu-Re-Formula Using UHPLC-Q-TOF/MS and HPLC-UV.

Authors:  Xin Shao; Jie Zhao; Xu Wang; Yi Tao
Journal:  J Anal Methods Chem       Date:  2018-03-11       Impact factor: 2.193

5.  Pharmacokinetics of Active Ingredients of Salvia miltiorrhiza and Carthamus tinctorius in Compatibility in Normal and Cerebral Ischemia Rats: A Comparative Study.

Authors:  Ying Jin; Li Yu; Fangfang Xu; Jie Zhou; Bing Xiong; Yinshan Tang; Xiaohong Li; Lanying Liu; Weifeng Jin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.